Cargando…
Retracted: MicroRNA-641 Inhibits Endometrial Cancer Progression via Targeting AP1G1
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356461/ https://www.ncbi.nlm.nih.gov/pubmed/37476342 http://dx.doi.org/10.1155/2023/9891212 |
Ejemplares similares
-
Retracted: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Analysis of Prognostic Factors and Treatment Modes of Patients with Recurrent Endometrial Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: MicroRNA-let-7 Targets HMGA2 to Regulate the Proliferation, Migration, and Invasion of Colon Cancer Cell HCT116
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Multivariate Analysis of Recurrence after Hysteroscopic Diagnosis and Treatment of Endometrial Polyps following IVF-ET Failure
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
por: Alternative Medicine, Evidence-Based Complementary and
Publicado: (2021)